Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4

Kidney International Reports - United States
doi 10.1016/j.ekir.2017.07.004
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Interstitial Disease of Autosomal Dominant Polycystic Kidney Disease

Journal of Physiology Studies
2014English

Ectopic (Pelvic) Autosomal Dominant Polycystic Kidney Disease

Internal Medicine
Internal MedicineMedicine
2010English

TRPP2 and Autosomal Dominant Polycystic Kidney Disease

Biochimica et Biophysica Acta - Molecular Basis of Disease
Molecular MedicineMolecular Biology
2007English

Predictors of Autosomal Dominant Polycystic Kidney Disease Progression

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2014English

Recent Advances in Autosomal-Dominant Polycystic Kidney Disease

Internal Medicine Journal
Internal Medicine
2016English

Seminal Vesicles in Autosomal Dominant Polycystic Kidney Disease

2015English

Intracranial Cysts in Autosomal Dominant Polycystic Kidney Disease

Journal of Neurosurgery
SurgeryNeurology
1995English

Haplotype Analysis in Autosomal Dominant Polycystic Kidney Disease.

Journal of Medical Genetics
Genetics
1995English

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

New England Journal of Medicine
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy